Jaundice laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 15: Line 15:
***  Conjugated bilirubin is <1 mg/dL (17 micromol/L) if the total bilirubin is <5 mg/dL, or less than 20 percent of the total bilirubin if the total bilirubin is >5 mg/dL (85 micromol/L).<ref name="pmid21250253">{{cite journal |vauthors=Walker HK, Hall WD, Hurst JW, Stillman AE |title= |journal= |volume= |issue= |pages= |year= |pmid=21250253 |doi= |url=}}</ref>
***  Conjugated bilirubin is <1 mg/dL (17 micromol/L) if the total bilirubin is <5 mg/dL, or less than 20 percent of the total bilirubin if the total bilirubin is >5 mg/dL (85 micromol/L).<ref name="pmid21250253">{{cite journal |vauthors=Walker HK, Hall WD, Hurst JW, Stillman AE |title= |journal= |volume= |issue= |pages= |year= |pmid=21250253 |doi= |url=}}</ref>
* FBC detect haemolysis.
* FBC detect haemolysis.
** ESR may be elevated - for example, in PBC.
* ESR may be rise in PBC.
** Lactate dehydrogenase is raised in haemolysis.
* Lactate dehydrogenase elevated in haemolysis.
** LFTs:
* LFTs:
*** Alkaline phosphatase: considerably increased with either extrahepatic or intrahepatic biliary disease. The most common diseases associated with raised alkaline phosphatase include:
** Alkaline phosphatase: considerably increased with either extrahepatic or intrahepatic biliary disease. The most common diseases associated with raised alkaline phosphatase include:
**** Gallstones causing bile duct obstruction.
*** Gallstones causing bile duct obstruction.
**** Pancreatic cancer.
*** Pancreatic cancer.
**** Pregnancy.
*** Pregnancy.
**** Drugs.
*** Drugs.
**** More rarely, PBC.
*** More rarely, PBC.
*** Serum transaminases are usually very high in hepatocellular disease (like viral hepatitis) but more modestly elevated in chronic hepatocellular damage and obstruction:
** Serum transaminases are usually very high in hepatocellular disease (like viral hepatitis) but more modestly elevated in chronic hepatocellular damage and obstruction:
**** Aspartate aminotransferase (AST) is raised more than alanine aminotransferase (ALT) in cirrhosis, intrahepatic neoplasia, haemolytic jaundice and alcoholic hepatitis.
*** Aspartate aminotransferase (AST) is raised more than alanine aminotransferase (ALT) in cirrhosis, intrahepatic neoplasia, haemolytic jaundice and alcoholic hepatitis.
**** ALT is raised more than AST in acute hepatitis and in extrahepatic obstruction.
*** ALT is raised more than AST in acute hepatitis and in extrahepatic obstruction.
**** ALT levels of less than 100 IU/L with jaundice suggest obstructive jaundice.
*** ALT levels of less than 100 IU/L with jaundice suggest obstructive jaundice.
**** ALT over 400 IU/L suggests diffuse acute hepatocellular damage (for example, in viral hepatitis).
*** ALT over 400 IU/L suggests diffuse acute hepatocellular damage (for example, in viral hepatitis).
**** ALT between 150-400 IU/L suggests chronic active hepatitis or viral or drug-induced hepatitis.
*** ALT between 150-400 IU/L suggests chronic active hepatitis or viral or drug-induced hepatitis.
**** Very high levels of ALT (over 1,000 IU/L) suggest acute parenchymal disease.
*** Very high levels of ALT (over 1,000 IU/L) suggest acute parenchymal disease.
*** Gamma-glutamyltransferase (GGT):
** Gamma-glutamyltransferase (GGT):
**** GGT is sensitive but not specific for excess alcohol intake.
*** GGT is sensitive but not specific for excess alcohol intake.
**** A raised MCV with raised GGT is suggestive of alcohol abuse and, if accompanied by raised ALT, suggests liver cell damage.
*** A raised MCV with raised GGT is suggestive of alcohol abuse and, if accompanied by raised ALT, suggests liver cell damage.
**** Biliary obstruction and hepatic malignancies cause very high GGT levels (x 10 normal).
*** Biliary obstruction and hepatic malignancies cause very high GGT levels (x 10 normal).
**** Raised GGT with raised alkaline phosphatase (over x 3 normal) suggests cholestasis.
*** Raised GGT with raised alkaline phosphatase (over x 3 normal) suggests cholestasis.
** Hepatitis serology should be done in all patients with cholestasis, as differentiating hepatitis from extrahepatic obstructive causes may be very difficult.
* Hepatitis serology should be done in all patients with cholestasis, as differentiating hepatitis from extrahepatic obstructive causes may be very difficult.
** Prothrombin time may be prolonged because of vitamin K malabsorption. Injection of vitamin K will correct deficiency in cholestasis but not in parenchymal liver disease.
* Prothrombin time may be prolonged because of vitamin K malabsorption. Injection of vitamin K will correct deficiency in cholestasis but not in parenchymal liver disease.
** Serum antinuclear antibodies (ANAs), anti-smooth muscle antibody (ASMA): the hallmark of PBC is antimitochondrial antibodies (90-95% of patients with PBC are positive); ANA is positive in 20-50% of patients with PBC.
* Serum antinuclear antibodies (ANAs), anti-smooth muscle antibody (ASMA): the hallmark of PBC is antimitochondrial antibodies (90-95% of patients with PBC are positive); ANA is positive in 20-50% of patients with PBC.
** Serum immunoglobulins and serum electrophoresis in acute hepatitis when autoimmune hepatitis is suspected. IgG is raised in acute hepatitis, IgM is raised in autoimmune disease, PBC or chronic infection.
* Serum immunoglobulins and serum electrophoresis in acute hepatitis when autoimmune hepatitis is suspected. IgG is raised in acute hepatitis, IgM is raised in autoimmune disease, PBC or chronic infection.
** Alpha-1-antitrypsin levels: deficiency causes cirrhosis and emphysema.
* Alpha-1-antitrypsin levels:
** Ferritin to screen for haemochromatosis.
** deficiency causes cirrhosis
 
Inalcoholic hepatitis the aspartate aminotransferase:alanine aminotransferase ratio is > 2 (AST:ALT)


==References==
==References==

Revision as of 19:45, 5 February 2018

Jaundice Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Jaundice from other Conditions

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Electrocardiogram

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Jaundice laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Jaundice laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Jaundice laboratory findings

CDC on Jaundice laboratory findings

Jaundice laboratory findings in the news

Blogs on Jaundice laboratory findings

Directions to Hospitals Treating Jaundice

Risk calculators and risk factors for Jaundice laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory Findings

  • Laboratory findings consistent with the diagnosis of jaundice include:
    • An elevated concentration of serum total bilirubin. the upper limit of normal is >1 mg/dL or >1.3 mg/d in some laboratories. Jaundice usually becomes clinically apparent when the serum total bilirubin concentration is greater than 2 to 3 mg/dL , but threshold for clinically apparent jaundice may vary among patients.[1]
  • Hyperbilirubinemia can be further categorized as conjugated or unconjugated:
    • Conjugated hyperbilirubinemia:
      •  Serum conjugated bilirubin concentration >0.4 mg/dL (6.8 micromol/L).
      • Direct bilirubin >1 mg/dL (17 micromol/L) if the total bilirubin is <5 mg/dL (85 micromol/L), or more than 20 percent of the total bilirubin if the total bilirubin is >5 mg/dL(85 micromol/L).[1]
    • Unconjugated hyperbilirubinemia:
      •  Conjugated bilirubin is <1 mg/dL (17 micromol/L) if the total bilirubin is <5 mg/dL, or less than 20 percent of the total bilirubin if the total bilirubin is >5 mg/dL (85 micromol/L).[1]
  • FBC detect haemolysis.
  • ESR may be rise in PBC.
  • Lactate dehydrogenase elevated in haemolysis.
  • LFTs:
    • Alkaline phosphatase: considerably increased with either extrahepatic or intrahepatic biliary disease. The most common diseases associated with raised alkaline phosphatase include:
      • Gallstones causing bile duct obstruction.
      • Pancreatic cancer.
      • Pregnancy.
      • Drugs.
      • More rarely, PBC.
    • Serum transaminases are usually very high in hepatocellular disease (like viral hepatitis) but more modestly elevated in chronic hepatocellular damage and obstruction:
      • Aspartate aminotransferase (AST) is raised more than alanine aminotransferase (ALT) in cirrhosis, intrahepatic neoplasia, haemolytic jaundice and alcoholic hepatitis.
      • ALT is raised more than AST in acute hepatitis and in extrahepatic obstruction.
      • ALT levels of less than 100 IU/L with jaundice suggest obstructive jaundice.
      • ALT over 400 IU/L suggests diffuse acute hepatocellular damage (for example, in viral hepatitis).
      • ALT between 150-400 IU/L suggests chronic active hepatitis or viral or drug-induced hepatitis.
      • Very high levels of ALT (over 1,000 IU/L) suggest acute parenchymal disease.
    • Gamma-glutamyltransferase (GGT):
      • GGT is sensitive but not specific for excess alcohol intake.
      • A raised MCV with raised GGT is suggestive of alcohol abuse and, if accompanied by raised ALT, suggests liver cell damage.
      • Biliary obstruction and hepatic malignancies cause very high GGT levels (x 10 normal).
      • Raised GGT with raised alkaline phosphatase (over x 3 normal) suggests cholestasis.
  • Hepatitis serology should be done in all patients with cholestasis, as differentiating hepatitis from extrahepatic obstructive causes may be very difficult.
  • Prothrombin time may be prolonged because of vitamin K malabsorption. Injection of vitamin K will correct deficiency in cholestasis but not in parenchymal liver disease.
  • Serum antinuclear antibodies (ANAs), anti-smooth muscle antibody (ASMA): the hallmark of PBC is antimitochondrial antibodies (90-95% of patients with PBC are positive); ANA is positive in 20-50% of patients with PBC.
  • Serum immunoglobulins and serum electrophoresis in acute hepatitis when autoimmune hepatitis is suspected. IgG is raised in acute hepatitis, IgM is raised in autoimmune disease, PBC or chronic infection.
  • Alpha-1-antitrypsin levels:
    • deficiency causes cirrhosis

References

  1. 1.0 1.1 1.2 Walker HK, Hall WD, Hurst JW, Stillman AE. PMID 21250253. Missing or empty |title= (help)

Template:WH Template:WS